Design & Qualification of a mRNA Expression Assay for Relative Potency Determination of an AAV Based Gene Therapy Product

Time: 2:00 pm
day: Conf Day One Bioassays PM


  • The mRNA expression assay as a surrogate relative potency method in early phase development
  • Strategies to eliminate amplification of contaminating DNA
  • Method qualification to support release of GMP material